Latest Conference Articles

Study shows that rivastigmine provides an equal or larger number of quality-adjusted life-years at a lower cost than other treatments.

Patients treated with Levadex, an orally inhaled dihydroergotamine, experienced significant migraine pain relief, even when treated hours after symptom onset.

Study results presented at AAN 2011 show that an experimental oral drug reduces the loss in ambulatory function in boys with Duchenne muscular dystrophy.

Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety.

Film and television actress Lea Thompson is the host of the American Academy of Neurology Foundation's latest patient education video and guidebook.

The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study.

The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain.

When a dementia diagnosis isn't Alzheimer's diease, the neurologist's job becomes much trickier.

When a neurologist encounters a patient with a form of NBIA, it's often their first patient with NBIA.

Scheduling, session topics, satellite symposia, and other information for physicians planning to attend AACE 2011.

Dr. Bruce Miller previews what he will be discussing about frontotemporal dementia at the upcoming American Academy of Neurology Annual Meeting.

Dr. Jeffrey Burns previews what he will be discussing about Alzheimer's disease at the upcoming American Academy of Neurology Annual Meeting.

Scheduling, session topics, keynote speakers, and other information for physicians planning to attend AAN 2011.

How long should a patient take an antiplatelet drug to reduce clotting following a stent procedure?

The H2H initiative includes the use of innovative health technologies such as HIT solutions, home monitoring devices, and telehealth resources.

EHRs address a key barrier to care as cardiologists lack the information and the tools to apply their knowledge to all of their patients all of the time.

Study results show Rheos implantable device is effective at lowering blood pressure in patients with drug-resistant hypertension.

RIVAL study shows radial access for coronary interventions reduces vascular complications.

No significant differences on cardiovascular outcomes were seen in a trial that compared ARBs to CCBs in patients with glucose tolerance and hypertension.

Combination calcium channel blocker and angiotensin II receptor blocker proves most effective in a study of elderly patients with hypertension.

Dr. Joe Kim speaks with Dr. Ethan Anderson about what's being discussed at ACC's 60th Annual Scientific Sessions.

Dr. Joe Kim speaks with Bruce Brandes of Airstrip Technologies about the company's new partnership with General Electric.

Study shows that a long-acting zotarolimus-eluting stent is effective in treating de novo lesions in native coronary arteries.

Study shows that percutaneous treatment of mitral regurgitation using MitraClip is no better than a surgical approach.

Studies comparing CABG and medical therapy in patients with heart failure show that viable myocardium has no effect on mortality.

Physicians from several large health systems share their insights and strategies for improving the quality of cardiac care delivered to patients.

Dr. Joe Kim shares his thoughts about a session during which cardiologists debated about the controversies associated with electrophysiology.

Can pulse pressure predicted white coat effect in treated hypertensive patients?

Dr. Douglas Moodie shares his concerns about what is going to happen with health care under ObamaCare.

Dr. Julie Atay discusses the two main objectives of her poster which evaluated the cost analysis of substituting Dabigatran for Warfarin.